Drugs Pharma

Moderna in $35 million licensing deal with CytomX

Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.

Read More
Drugs Medical Pharma

Scientists use nanoparticle therapy to cure arthritis in mice

A nanoparticle treatment has "cured" mice that had a genetic arthritis condition, according to Scripps Research, a nonprofit US medical research institution.

Read More